These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2185490)

  • 21. Immunosuppressive drugs.
    Transplant Proc; 1983 Mar; 15(1 Pt 1):431-580. PubMed ID: 6836718
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine and murine allergic contact dermatitis.
    Rullan PP; Barr RJ; Cole GW
    Arch Dermatol; 1984 Sep; 120(9):1179-83. PubMed ID: 6332577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The discovery and development of cyclosporine (Sandimmune).
    Borel JF; Kis ZL
    Transplant Proc; 1991 Apr; 23(2):1867-74. PubMed ID: 2053181
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine inhibits nonspecific transfusion-induced immunity in dogs.
    Kyriakides GK; Esquenazi V; Olson L; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1432-3. PubMed ID: 2978877
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 27. Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness?
    Hakim M; White DJ; Cory-Pearce R; English TA; Wallwork J
    J Heart Transplant; 1985 Feb; 4(2):217-9. PubMed ID: 3916489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals.
    Mason J
    Pharmacol Rev; 1990 Sep; 41(3):423-34. PubMed ID: 2185493
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppression: building on Sandimmune (cyclosporine).
    Borel JF
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):149-53. PubMed ID: 2964748
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings of the Eleventh International Congress of the Transplantation Society. August 3-8, 1986, Helsinki, Finland.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):905-1832. PubMed ID: 3547887
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporine.
    Transplant Proc; 1983 Sep; 15(3):1907-35. PubMed ID: 6623625
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporin A and G inhibition of cytokine production.
    Szturm K; Jeffery JR; Rush DN; McKenna RM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):857. PubMed ID: 2705251
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine.
    Babany G; Morris RE; Babany I; Kates RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):259-62. PubMed ID: 3275773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID; Thomson M; Kelly DA
    Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive activities of cyclosporine metabolites M17 and M21 within a bioassay based on inhibition of interleukin-2 production.
    Heidecke CD; Nicolaus C; Schäfer K; Groenewoud B; Bollschweiler E; Hölscher M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):839. PubMed ID: 2784905
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressive therapy and heart transplant. Personal experience].
    Alfani D; Toscano M; Mazzesi G; Berloco P; Rossi M; Renna Molajoni E; Pretagostini R; Caricato M; Marino B; Cortesini R
    Minerva Chir; 1989 Jan; 44(1-2):47-50. PubMed ID: 2651991
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
    Babany G; Morris RE; Babany I; Shepherd S; Kates RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):893-9. PubMed ID: 2649657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathophysiology of Sandimmune (cyclosporine) in man and animals.
    Mason J
    Pediatr Nephrol; 1990 Nov; 4(6):686-704. PubMed ID: 2088472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A single-center controlled clinical study with Sandimmune Neoral after kidney transplantation].
    Matl I; Vítko S; Lácha J; Horcicková M; Nosková L; Símová M; Táborský P; Viklický O; Hulínský V; Lánská V
    Vnitr Lek; 1997 Nov; 43(11):703-6. PubMed ID: 9650498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Induction of long-term tolerance by cyclosporine in orthotopic kidney allografts in rats].
    Rodríguez J; Jiménez G; Arias J; Aller MA; Lorente L; Arias L; Arias JI; Brandau D; Durán H
    Arch Esp Urol; 1987 May; 40(4):235-40. PubMed ID: 3307645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.